Clinical Trials
2 trialsNCT02489903 2025-03-17
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
Phase 2 Completed
NCT00424723 2010-08-12
Pemetrexed in Patients With Advanced Neuroendocrine Tumors
Dana-Farber Cancer Institute
Phase 2 Completed